Company Name: |
Daicel Chiral Technologies (China)CO.,LTD
|
Tel: |
021-50460086-9 15921403865 |
Email: |
han_yajun@dctc.daicel.com |
Products Intro: |
Product Name:4-(5-chloro-2-(2-methyl-4-(2-methylbenzamido)benzamido)phenyl)-4-oxobutanoic acid CAS:1346599-56-1 Purity:95%HPLC Package:10MG;25MG;50MG;100MG Remarks:DCTI-C-1351
|
Company Name: |
BOC Sciences
|
Tel: |
1-631-485-4226; 16314854226 |
Email: |
info@bocsci.com |
Products Intro: |
Product Name:Tolvaptan impurity 1 CAS:1346599-56-1 Remarks:One of the impurities of Tolvaptan, which has been found to be a vasopressin V2 receptor antagonist
|
Company Name: |
Shenzhen ruikai de biotechnology co., ltd.
|
Tel: |
0755-61348847 17820674378 |
Email: |
2682116078@qq.com |
Products Intro: |
Product Name:Tolvaptan Impurity 1 CAS:1346599-56-1 Purity:98%HPLC Package:10mg;25mg;50mg;100mg
|
|
| PRTSBHBGYFDAAS-UHFFFAOYSA-N Basic information |
Product Name: | PRTSBHBGYFDAAS-UHFFFAOYSA-N | Synonyms: | PRTSBHBGYFDAAS-UHFFFAOYSA-N;4-(5-chloro-2-(2-methyl-4-(2-methylbenzamido)benzamido)phenyl)-4-oxobutanoic acid;Tolvaptan Impurity 1 (DM-4103);Benzenebutanoic acid, 5-chloro-2-[[2-methyl-4-[(2-methylbenzoyl)amino]benzoyl]amino]-γ-oxo- | CAS: | 1346599-56-1 | MF: | C26H23ClN2O5 | MW: | 478.92 | EINECS: | | Product Categories: | | Mol File: | 1346599-56-1.mol | |
| PRTSBHBGYFDAAS-UHFFFAOYSA-N Chemical Properties |
Boiling point | 596.0±50.0 °C(Predicted) | density | 1.365±0.06 g/cm3(Predicted) | pka | 4.35±0.17(Predicted) |
| PRTSBHBGYFDAAS-UHFFFAOYSA-N Usage And Synthesis |
Uses | A Tolvaptan (T536650) Impurity. | Definition | ChEBI: DM-4103 is a 4-oxo monocarboxylic acid that is 4-oxobutanoic acid substituted at position 4 with a 5-chloro-2-[2-methyl-4-(2-methylbenzamido)benzamido]phenyl group. An oxobutyric acid metabolite of the vasopressin V2-receptor antagonist tolvaptan. It has a role as a drug metabolite. It is a 4-oxo monocarboxylic acid and a benzenedicarboxamide. It is functionally related to a tolvaptan. |
| PRTSBHBGYFDAAS-UHFFFAOYSA-N Preparation Products And Raw materials |
|